Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): A jungle of cell-cell interactions or a therapeutic opportunity?

Prostaglandins

Volumn 53, Issue 2, 1997, Pages 107-137

  Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

15 epi Lipoxins; aspirin; cell cell interaction; lipoxin

Indexed keywords

15 EPILIPOXIN; ACETYLSALICYLIC ACID; COMPLEMENTARY DNA; CYTOKINE; ICOSANOID; LEUKOTRIENE A4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; LIPOXIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIOSYNTHESIS; CELL ADHESION; CELL INTERACTION; DRUG MECHANISM; THROMBOSIS; VASODILATATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACIDS; ASPIRIN; CELL COMMUNICATION; HYDROXYEICOSATETRAENOIC ACIDS; LEUKOTRIENE A4; LIPOXINS; MODELS, BIOLOGICAL; RECEPTORS, CELL SURFACE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

EID: 0030937154     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(97)00001-4     Document Type: Article

References (119)

1. Marcus, A.J., and Hajjar, D.P. Vascular transcellular signaling. J. Lipid Res. 34: 2017. 1993.
2. Serhan, C.N., Hamberg, M., and Samuelsson, B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. USA 81: 5335. 1984.
3. Samuelsson, B., Dahlén, S.E., Lindgren, J.Å., Rouzer, C.A., and Serhan, C.N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171. 1987.
4. Serhan, C.N. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim. Biophys. Acta 1212: 1. 1994.
5. Rokach, J., and Fitzsimmons, B. The lipoxins. Int. J. Biochem. 20: 753. 1988.
6. Ford-Hutchinson, A.W. Arachidonate 15-lipoxygenase; characteristics and potential biological significance. Eicosanoids 4: 65. 1991.
7. Levy, B.D., Romano, M., Chapman, H.A., Reilly, J.J., Drazen, J., and Serhan, C.N. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J. Clin. Invest. 92: 1572.1993.
8. Nassar, G.M., Morrow, J.D., Roberts, L.J., II, Lakkis, F.G., and Badr, K.F. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J. Biol. Chem. 269:27631. 1994.
9. Sigal, E., and Conrad, D.J. Human 15-lipoxygenase: a potential effector molecule for interleukin-4. Adv. Prostaglandin Thromboxane Leukot. Res. 22: 309. 1994.
10. Katoh, T., Lakkis, F.G., Makita, N., and Badr, K.F. Co-regulated expression of glomerular 12/15-lioxygenase and interleukin-4 mRNA in rat nephrotoxic nephritis. Kidney Int. 46: 341. 1994.
11. Badr, K.F., and Lakkis, F.G. Lipoxygenase products in normal and diseased glomeruli. Ann. N. Y. Acad. Sci. 744:216. 1994.
12. 2-like' cells in allergy and asthma: pharmacological perspectives. Trends Pharmacol. Sci. 15: 324. 1994.
13. Pouliot, M., McDonald, P.P., Borgeat, P., and McColl, S.R. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J. Exp. Med. 179: 1225. 1994.
14. Ring, W.L., Riddick, C.A., Baker, J.R., Munafo, D.A., and Bigby, T.D. Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte-macrophage colony stimulating factor and interleukin-3. J. Clin. Invest. 97: 1293. 1996.
15. L'Heureux, G.P., Bourgoin, S., Jean, N., McColl, S.R., and Naccache, P.H. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: Interleukin-8, but not NAP-2 or GROAα, stimulates phospholipase D activity. Blood 85: 522.1995.
16. 4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity. Proc. Natl. Acad. Sci. USA 85: 8340. 1988.
17. 4 and related compounds in smooth muscle preparations and on the microcirculation in vivo. Adv. Exp. Med. Biol. 229: 107. 1988.
18. 4 in airway smooth muscle. Agents Actions 26:93. 1989.
19. Dahlén, S.-E., and Serhan, C.N. In: Lipoxygenases and Their Products. Lipoxins: bioactive lipoxygenase interaction products. (Wong, A. & Crooke, S. T., eds.) Academic Press, San Diego. 1991, p. 235.
20. Katoh, T., Takahashi, K., DeBoer, D.K., Serhan, C.N., and Badr, K.F. Renal hemodynamic actions of lipoxins in rats: a comparative physiological study. Am. J. Physiol. 263: F436. 1992.
21. Clària, J., Lee, M.H., and Serhan, C.N. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol. Med. 2: 583. 1996.
22. 4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin. Sci. 77: 195. 1989.
23. 4: structure-function relationships. Biochem. Biophys. Res. Commun. 180: 1416. 1991.
24. 4: a novel anti-inflammatory molecule? [editorial]. Thorax 50: 111. 1995.
25. 4 in rat glomerular mesangial cells: evidence for competition at a common receptor. Proc. Natl. Acad. Sci. USA 86: 3438. 1989.
26. Ng, C.F., Lam, B.K., Pritchard, K.A., Jr., Stemerman, M.B., Hejny, P., and Wong, P.Y. Agonist-dependent generation of lipoxins from rat basophilic leukemia cell (RBL-1). Biochim. Biophys. Acta 1004: 332. 1989.
27. Fiore, S., and Serhan, C.N. Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J. Exp. Med. 172: 1451. 1990.
28. Chavis, C., Chanez, P., Vachier, I., Bousquet, J., Michel, F.B., and Godard, P. 5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers. Biochem. Biophys. Res. Commun. 207: 273. 1995.
29. Chavis, C., Vachier, I., Chanez, P., Bousquet, J., and Godard, P. 5(S),15(S)-Dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J. Exp. Med. 183: 1633. 1996.
30. Thomas, E., Leroux, J.L., Blotman, F., and Chavis, C. Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis. Inflamm. Res. 44: 121. 1995.
31. Edenius, C., Haeggström, J., and Lindgren, J.A. Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human plateletgranulocyte suspensions [published erratum appears in Biochem Biophys Res Commun 1989 Feb 28;159(1):370]. Biochem. Biophys. Res. Commun. 157: 801. 1988.
32. 4 by platelet 12-lipoxygenase in vitro. J. Clin. Invest. 85: 772. 1990.
33. 4 transfer. Trends Pharmacol. Sci. 14: 351. 1993.
34. 4 and epoxytetraenes: stabilization of eicosanoids by liposomes. Biochem. Biophys. Res. Commun. 159: 477. 1989.
35. 4. Adv. Prostaglandin Thromboxane Leukot. Res. 20: 54. 1990.
36. Stenke, L, Edenius, C., Samuelsson, J., and Lindgren, J.A. Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia. Blood 78: 2989. 1991.
37. Stenke, L., Mansour, M., Edenius, C., Reizenstein, P., and Lindgren, J.A. Formation and proliferative effects of lipoxins in human bone marrow. Biochem. Biophys. Res. Commun. 180: 255. 1991.
38. Corey, E.J., and Mehrotra, M.M. Tetrahedron Lett. 27: 5173. 1986.
39. Sheppard, K.A., Greenberg, S.M., Funk, C.D., Romano, M., and Serhan, C.N. Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase. Biochim. Biophys. Acta 1133: 223. 1992.
40. Romano, M., and Serhan, C.N. Lipoxin generation by permeabilized human platelets. Biochemistry 31: 8269. 1992.
41. Romano, M., Chen, X.S., Takahashi, Y., Yamamoto, S., Funk, C.D., and Serhan, C.N. Lipoxin synthase activity of human platelet 12-lipoxygenase. Biochem. J. 296: 127. 1993.
42. Lehr, H.-A., Olofsson, A.M., Carew, T.E., et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab. Invest. 71: 380. 1994.
43. Lehr, H.-A., Frei, B., and Arfors, K.-E. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc. Natl. Acad. Sci. USA 91: 7688. 1994.
44. Clària, J., and Serhan, C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA 92: 9475. 1995.
45. Herschman, H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta 1299: 125. 1996.
46. Hla, T., and Neilson, K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA 89: 7384. 1992.
47. Holtzman, M.J., Zhang, V., Hussain, H., Roswit, W.T., and Wilson, J.D. Prostaglandin H synthase and lipoxygenase gene families in the epithelial cell barrier. Ann. N. Y. Acad. Sci. 744: 58. 1994.
48. 2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Circulation 92: 3194. 1995.
49. Giovannucci, E., Egan, K.M., Hunter, D.J., et al. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333: 609. 1995.
50. Mayadas, T.N., Mendrick, D.L., Brady, H.R., et al. Acute passive antiglomerular basement membrane nephritis in P-selectin-deficient mice. Kidney Int. 49: 1342. 1996.
51. Garrick, R., and Wong, P.Y. Enzymatic formation and regulatory function of lipoxins and leukotriene B4 in rat kidney mesangial cells. Adv. Exp. Med. Biol. 314: 361. 1991.
52. Edenius, C., Kumlin, M., Björk, T., Anggard, A., and Lindgren, J.A. Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett. 272: 25. 1990.
53. 4 in human platelets. Ph.D. thesis in Medical Biochemistry (Karolinska Institute, Stockholm). 1996.
54. Tornhamre, S., Gigou, A., Edenius, C., Lellouche, J.P., and Lindgren, J.A. Conversion of 5,6-dihydroxyeicosatetraenoic acids. A novel pathway for lipoxin formation by human platelets. FEBS Lett. 304: 78. 1992.
55. Brezinski, M.E., and Serhan, C.N. Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. Proc. Natl. Acad. Sci. USA 87: 6248. 1990.
56. Pettitt, T.R., Rowley, A.F., and Secombes, C.J. Lipoxins are major lipoxygenase products of rainbow trout macrophages. FEBS Lett. 259: 168. 1989.
57. Pettitt, T.R., Rowley, A.F., Barrow, S.E., Mallet, A.I., and Secombes, C.J. Synthesis of lipoxins and other lipoxygenase products by macrophages from the rainbow trout, Oncorhynchus mykiss. J. Biol. Chem. 266: 8720. 1991.
58. Knight, J., Holland, J.W., Bowden, L.A., Halliday, K., and Rowley, A.F. Eicosanoid generating capacities of different tissues from the rainbow trout, Oncoihynchus mykiss. Lipids 30: 451. 1995.
59. Secombes, C.J., Clements, K., Ashton, I., and Rowley, A.F. The effect of eicosanoids on rainbow trout, Oncorhynchus mykiss, leucocyte proliferation. Vet. Immunol. Immunopathol. 42: 367. 1994.
60. Sharp, G.J., Pettitt, T.R., Rowley, A.F., and Secombes, C.J. Lipoxin-induced migration of fish leukocytes. J. Leukoc. Biol. 51: 140. 1992.
61. Gronert, K., Virk, S.M., and Herman, C.A. Thrombocytes are the predominant source of endogenous sulfidopeptide leukotrienes in the bullfrog (Rana catesbeiana). Biochim. Biophys. Acta 2255: 311. 1995.
62. Stenke, L., Reizenstein, P., and Lindgren, J.A. Leukotrienes and lipoxinsnew potential performers in the regulation of human myelopoiesis. Leukemia Res. 18: 727. 1994.
63. Rowley, A.F. Lipoxin formation in fish leucocytes. Biochim. Biophys. Acta 1084: 303. 1991.
64. Rowley, A.F., Lloyd-Evans, P., Barrow, S.E., and Serhan, C.N. Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates. Biochemistry 33: 856. 1994.
65. Brady, H.R., and Serhan, C.N. Adhesion promotes transcellular leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: inhibition by antibodies against CD18 and L-selection. Biochem. Biophys. Res. Commun. 186: 1307. 1992.
66. 4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. Kidney Int. 47: 1295. 1995.
67. 4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am. Rev. Respir. Dis. 141: 1453. 1990.
68. 4. Impact of aspirin therapy. Circulation 86: 56. 1992.
69. 4 by stimulated human whole blood. Biol. Mass Spectrom. 20: 45. 1991.
70. Sud'ina, G.F., Mirzoeva, O.K., Shchukin, I.A., et al. Lipoxins: study of various biosynthesis pathways. Biokhimiia 56: 1113. 1991.
71. 4 and decreased lipoxin formation in chronic myeloid leukemia. Adv. Prostaglandin Thromboxane Leukot. Res. 21B: 883. 1990.
72. 4 by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 585: 53. 1991.
73. 4 by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 428: 237. 1988.
74. Griffiths, W.J., Yang, Y., Sjövall, J., and Lindgren, J.Å. Electrospray/collision-induced dissociation mass spectrometry of mono-, di-and tri-hydroxylated lipoxygenase products, including leukotrienes of the Bseries and lipoxins. Rapid Commun. Mass Spectrom. 10: 183. 1996.
75. Brezinski, M.E., Gimbrone, M.A., Jr., Nicolaou, K.C., and Serhan, C.N. Lipoxins stimulate prostacyclin generation by human endothelial cells. FEBS Lett. 245: 167. 1989.
76. 4. FEBS Lett. 263: 117. 1990.
77. 4-induced polymorphonuclear neutrophil-dependent cytotoxicity to human vascular endothelium in vitro. Arthritis Rheum. 38: 768. 1995.
78. 4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49: 230. 1994.
79. 4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92: 75. 1993.
80. 4-induced inflammation in the hamster cheek pouch. Acta Physiol. Scand. 137: 571. 1989.
81. 4. Adv. Exp. Med. Biol. 314: 185. 1991.
82. 4 receptor interaction. Biochemistry 34: 16678. 1995.
83. 4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J. Immunol. 156: 2264. 1996.
84. 4 inhibits phosphoinositide hydrolysis in human neutrophils. Biochem. Biophys. Res. Commun. 167: 1022. 1990.
85. Ramstedt, U., Serhan, C.N., Nicolaou, K.C., Webber, S.E., Wigzell, H., and Samuelsson, B. Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: studies on stereospecificity of inhibition and mode of action. J. Immunol. 138: 266. 1987.
86. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183: 137. 1996.
87. Popov, G.K., Nekrasov, A.S., Khshivo, A.L., Pochinshii, A.G., Lankin, V.Z., and Vikhert, A.M. Effects of lipoxin B on colony-forming capacity of human peripheral blood mononuclear cells in diffusion chambers. Biull. Eksp. Biol. Med. 107: 80. 1989.
88. 4 on airway responses in asthmatic subjects. Am. Rev. Respir. Dis. 145: 1281. 1992.
89. Mayadas-Norton, T., Mendrick, D.L., Tang, T., et al. P-selectin deficient mice have increased neutrophil (PMN) influx and proteinuria in acute passive a-GBM nephritis model. FASEB J. 9: A269 (Abstract no. 1557). 1995.
90. 4. J. Pharmacol. Exp. Ther. 278: 950. 1996.
91. 2, lipoxins and leukotrienes on sleep and brain temperature of rats. Prostaglandins Leukot. Essent. Fatty Acids 51: 87. 1994.
92. 4 with human neutrophils. J. Biol. Chem. 267: 16168. 1992.
93. 4 receptors in HL-60 cells. Blood 81: 3395. 1993.
94. Papayianni, A., Takata, S., Serhan, C.N., and Brady, H.R. Counter-regulatory actions of leukotrienes (LT) and lipoxins (LX) on P-selectin expression on human endothelial cells and neutrophil-endothelial cell adhesion. J. Am. Soc. Nephrol. 4: 627 (abstract 126P). 1993.
95. 4, 5,6-dihydroxy-eicosatetraenoic acid and lipoxin A on guinea pig lung parenchyma and ileum smooth muscle. Res. Commun. Chem. Pathol. Pharmacol. 59: 423. 1988.
96. 4 for guinea-pig airway tissues. Br. J. Pharmacol. 95: 562. 1988.
97. Hansson, A., Serhan, C.N., Haeggström, J., Ingelman-Sundberg, M., and Samuelsson, B. Activation of protein kinase C by lipoxin A and other eicosanoids. Intracellular action of oxygenation products of arachidonic acid. Biochem. Biophys. Res. Commun. 134: 1215. 1986.
98. Shearman, M.S., Naor, Z., Sekiguchi, K., Kishimoto, A., and Nishizuka, Y. Selective activation of the gamma-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites. FEBS Lett. 243: 177. 1989.
99. 4 on signal transduction events in Friend erythroleukemia cells. Proc. Soc. Exp. Biol. Med. 201: 169. 1992.
100. 4 in human neutrophils. Am. J. Physiol. 267: C1525. 1994.
101. Ferez, H.D., Holmes, R., Kelly, E., McClary, J., and Andrews, W.H. Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils. Gene (Amst.) 118: 303. 1992.
102. 4 receptor. J. Exp. Med. 180: 253. 1994.
103. Post, G.R., and Brown, J.H. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J. 10: 741. 1996.
104. Toh, H., Ichikawa, A., and Narumiya, S. Molecular evolution of receptors for eicosanoids. FEBS Lett. 361: 17. 1995.
105. 4R). J. Am. Soc. Nephrol. 6: 762. 1995.
106. Weissmann, G. Aspirin. Sci. Am. 264: 84. 1991.
107. Giovannucci, E., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Ascherio, A., and Willett, W.C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 121: 241. 1994.
108. Schreinemachers, D.M., and Everson, R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138. 1994.
109. Marcus, A.J. Aspirin as prophylaxis against colorectal cancer. N. Engl. J. Med. 333: 656. 1995.
110. 4-ELISA. Lipids 28: 1047. 1993.
111. Mancini, J.A., O'Neill, G.P., Bayly, C., and Vickers, P.J. Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis. FEBS Lett. 342: 33. 1994.
112. Serhan, C.N., Fiore, S., Brezinski, D.A., and Lynch, S. Lipoxin Ai metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry 32: 6313. 1993.
113. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34: 14609. 1995.
114. Collins, P.W., and Djuric, S.W. Synthesis of therapeutically useful prostaglandin and prostacyclin analogs. Chem. Rev. 93: 1533. 1993.
115. Serhan, C.N., Nicolaou, K.C., Webber, S.E., et al. Lipoxin A. Stereochemistry and biosynthesis. J. Biol. Chem. 261: 16340. 1986.
116. 4, omega-hydroxylase (cytochrome P-450LTB omega). Biochim. Biophys. Acta 1168: 87. 1993.
117. 4 by human neutrophil microsomes. FEBS Lett. 315: 205. 1993.
118. Butcher, E.C. Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision process. Res. Immunol. 144: 695. 1993.
119. Datta, Y.H., Romano, M., Jacobson, B.C., Golan, D.E., Serhan, C.N., and Ewenstein, B.M. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation 92: 3304. 1995.